V
Victor M. Corman
Researcher at Charité
Publications - 289
Citations - 37158
Victor M. Corman is an academic researcher from Charité. The author has contributed to research in topics: Medicine & Middle East respiratory syndrome coronavirus. The author has an hindex of 64, co-authored 235 publications receiving 26011 citations. Previous affiliations of Victor M. Corman include Humboldt University of Berlin & Utrecht University.
Papers
More filters
Posted ContentDOI
Presence of SARS-CoV-2-reactive T cells in COVID-19 patients and healthy donors
Julian Braun,Lucie Loyal,Marco Frentsch,Daniel Wendisch,Philipp Georg,Florian Kurth,Stefan Hippenstiel,Manuela Dingeldey,Beate Kruse,Florent Fauchere,Emre Baysal,Maike Mangold,Larissa Henze,Roland Lauster,Roland Lauster,Marcus A. Mall,Kirsten Beyer,Jobst Röhmel,Jürgen Schmitz,Stefan Miltenyi,Ilja Demuth,Marcel A. Müller,Martin Witzenrath,Norbert Suttorp,Florian Kern,Ulf Reimer,Holger Wenschuh,Christian Drosten,Victor M. Corman,Claudia Giesecke-Thiel,Leif E. Sander,Andreas Thiel +31 more
TL;DR: This study is the first to directly measure SARS-CoV-2-reactive T cell responses providing critical tools for large scale testing, in depth epitope mapping and characterization of potential cross-reacting cellular immunity to SARS, as well as larger scale prospective cohort studies needed to assess whether their presence is a correlate of protection or pathology.
Journal ArticleDOI
Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020.
Chantal B.E.M. Reusken,Eeva Broberg,Bart L. Haagmans,Adam Meijer,Victor M. Corman,Anna Papa,Rémi N. Charrel,Christian Drosten,Marion Koopmans,Katrin Leitmeyer,ERLI-Net +10 more
TL;DR: Assessment of the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries found availability of primers/probes, positive controls and personnel were main implementation barriers.
Journal ArticleDOI
Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
Lucie Loyal,Lucie Loyal,Julian Braun,Julian Braun,Larissa Henze,Larissa Henze,Beate Kruse,Beate Kruse,Manuela Dingeldey,Manuela Dingeldey,Ulf Reimer,Florian Kern,Tatjana Schwarz,Maike Mangold,Maike Mangold,Clara Unger,Clara Unger,Friederike Dörfler,Shirin Kadler,Shirin Kadler,Jennifer Rosowski,Jennifer Rosowski,Kübrah Gürcan,Kübrah Gürcan,Zehra Uyar-Aydin,Zehra Uyar-Aydin,Marco Frentsch,Florian Kurth,Florian Kurth,Karsten Schnatbaum,Maren Eckey,Stefan Hippenstiel,Andreas C. Hocke,Marcel A. Müller,Marcel A. Müller,Birgit Sawitzki,Stefan Miltenyi,Friedemann Paul,Marcus A. Mall,Holger Wenschuh,Sebastian Voigt,Christian Drosten,Christian Drosten,Roland Lauster,Roland Lauster,Nils Lachman,LE Sander,Victor M. Corman,Victor M. Corman,Jobst Röhmel,Lil Meyer-Arndt,Andreas Thiel,Andreas Thiel,Claudia Giesecke-Thiel +53 more
TL;DR: In this article, the functional relevance of preexisting cross-immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a subject of intense debate.
Journal ArticleDOI
Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes
Jan Felix Drexler,Andreas Geipel,Alexander König,Victor M. Corman,Debby van Riel,Lonneke M. Leijten,Corinna M. Bremer,Andrea Rasche,Veronika M. Cottontail,Gael Darren Maganga,Mathias Schlegel,Marcel A. Müller,Alexander C. Adam,Stefan M. Klose,Aroldo José Borges Carneiro,Andreas Stöcker,Carlos Roberto Franke,Florian Gloza-Rausch,Joachim Geyer,A. P. Annan,Yaw Adu-Sarkodie,Samuel Oppong,Tabea Binger,Peter Vallo,Peter Vallo,Marco Tschapka,Rainer G. Ulrich,Wolfram H. Gerlich,Eric M. Leroy,Thijs Kuiken,Dieter Glebe,Christian Drosten +31 more
TL;DR: The data suggest that bats may have been ancestral sources of primate hepadnaviruses and HBV, and the observed zoonotic potential might affect concepts aimed at eradicating HBV.
Journal ArticleDOI
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children.
Jennifer Loske,Jobst Röhmel,Soeren Lukassen,Sebastian Stricker,Vladimir Gonçalves Magalhães,Johannes Liebig,Robert Lorenz Chua,Loreen Thürmann,Marey Messingschlager,Anke Seegebarth,Bernd Timmermann,Sven Klages,Markus Ralser,Birgit Sawitzki,Leif E. Sander,Victor M. Corman,Victor M. Corman,Christian Conrad,Sven Laudi,Marco Binder,Saskia Trump,Roland Eils,Roland Eils,Marcus A. Mall,Irina Lehmann,Irina Lehmann +25 more
TL;DR: In this paper, the authors characterized the single-cell transcriptional landscape in the upper airway of SARS-CoV-2-negative and age-matched children and corresponding samples from adults, covering an age range of 4 weeks to 77 years.